William K. Oh, a genitourinary oncologist with expertise in the use of systemic treatments for prostate cancer, was named chief medical officer of the Prostate Cancer Foundation.
Investigators from UCLA Health found using artificial intelligence to help map out the boundaries of cancerous prostate tissue can significantly reduce the risk of underestimating the extent of prostate cancer—an advancement that can help ensure an accurate diagnosis, precise treatment planning and effective surgical procedures.
